Pharmaceutical IP and competition law in South Africa: overview

Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie

A Q&A guide to pharmaceutical IP and competition law in South Africa.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

To read the full Q&A, visit Thomson Reuters Practical Law.

For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.

Alexis Apostolidis
Partner | Head of Competition Law Group
Danie-Dohmen-author
Danie Dohmen
Partner | Patent Attorney
Jenny Pienaar
Partner | Trade Mark Attorney
View Related Blogs
View All
news

New South African national research facility for local manufacturing of pharmaceuticals

A new national research facility of South Africa’s Council for Scientific and Industrial Research (CSIR) was officially opened on 7 October 2026. Known as FuturePHARMA, the facility forms part of th...

Adams NewsAfrica Ip updatesSouth Africa
news

Wits University seeks closer cooperation with WIPO

The Director General of the World Intellectual Property Organization (WIPO), Daren Tang, recently met with Professor Zeblon Vilakazi, the Vice-Chancellor and Principal of South Africa’s University o...

Adams NewsAfrica Ip updatesSouth Africa
news

Highlights of the Adams & Adams Africa Network Meeting

The 13th Adams & Adams Africa Network Meeting brought together more than 80 IP professionals and stakeholders from 25 countries under the theme ‘Playing to Win: Building Advantage Through IP’....

Adams NewsAfrica Ip updatesSouth Africa